Related Experiment Videos
Medical treatment for inflammatory bowel disease--refinements and new modalities
Journal of Internal Medicine
|January 1, 1997
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Long-term outcome of infliximab treatment in chronic active ulcerative colitis: a Swedish multicentre study of 250 patients.
Alimentary pharmacology & therapeutics·2016
New steroids for inflammatory bowel disease.
Inflammatory bowel diseases·2013
Kinetics of the soluble IL-1 receptor type I during treatment with an LCAP filter in patients with inflammatory bowel disease.
Journal of clinical apheresis·2012
Patients with ulcerative colitis responding to steroid treatment up-regulate glucocorticoid receptor levels in colorectal mucosa.
Journal of Crohn's & colitis·2010
The mode of actions of the Adacolumn therapeutic leucocytapheresis in patients with inflammatory bowel disease: a concise review.
Clinical and experimental immunology·2010
Clinical trial: the safety and short-term efficacy of recombinant cholera toxin B subunit in the treatment of active Crohn's disease.
Alimentary pharmacology & therapeutics·2009
A demographic perspective on longevity and healthspan: Rethinking population ageing through a positive and prospective lens.
Journal of internal medicine·2026
Snus, nicotine pouches and cardiovascular disease: Evidence, mechanisms, and the challenge of novel nicotine products.
Journal of internal medicine·2026
Cognitive safety of statin use in the elderly: Evidence from a nationally representative sample.
Journal of internal medicine·2026
European Consortium for Lipodystrophies consensus definition and classification framework for monogenic lipodystrophy.
Journal of internal medicine·2026
Upcoming therapies for steatotic liver disease: Translating breakthroughs into clinical practice.
Journal of internal medicine·2026
[Mesenchymal Stem Cells as Anti-Tumor Therapeutics-Current Status and Challenges].
Gan to kagaku ryoho. Cancer & chemotherapy·2026
A hospital-based HTA model to assess the economic and organizational impact of intravenous-to-subcutaneous monoclonal antibody transitions in oncology.
International journal of technology assessment in health care·2026